Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
Frontiers in Immunology|August 29, 2022
The role of the complement system in Multiple Sclerosis: A reviewNil Saez-Calveras, Olaf StuveFrontiers in Molecular Neuroscience|October 31, 2022
The validity of animal models to explore the pathogenic role of the complement system in multiple sclerosis: A reviewNil Saez-Calveras, Amy L Brewster, Olaf StuveTherapeutic Advances in Neurological Disorders|October 7, 2024
Exploring the association of disease-modifying therapies for multiple sclerosis and BTK inhibitors with epilepsyAfsaneh Shirani, Nil Saez-Calveras, Jack P Antel, et al.Journal of Alzheimer'S Disease : JAD|April 22, 2025
Hydrate to keep the amyloid awayNil Saez-Calveras, Makoto IshiiThe Neurohospitalist|April 26, 2024
Neuromyelitis Optica Spectrum Disorder Resembling Wernicke's Encephalopathy: A Case Report and Review of the LiteratureSloan Lynch, Nil Saez Calveras, Anik AminTherapeutic Advances in Neurological Disorders|March 6, 2023
Microglia as a cellular target of diclofenac therapy in Alzheimer's diseaseBarbara E Stopschinski, Rick A Weideman, Danni McMahan, et al.Therapeutic Advances in Neurological Disorders|March 30, 2023
Limb myorhythmia treated with chemodenervation: a case reportNil Saez-Calveras, Meredith Bryarly, Meagen SalinasJournal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 29, 2023
Episodic stuttering as the presenting manifestation of acute ischemic stroke: A case report and systematic literature reviewNil Saez-Calveras, Nguyen Tran, Conny Tran, et al.Therapeutic Advances in Neurological Disorders|February 23, 2026
Vedolizumab and the gut-CNS axis in multiple sclerosis: considering T cell licensing pathwaysAfsaneh Shirani, Olaf StuveExpert Opinion on Investigational Drugs|November 6, 2025
Glucagon‑like peptide‑1 receptor agonists in multiple sclerosis: therapeutic promise, challenges, and future directionsAfsaneh Shirani, Olaf StuvePageof 9